This study was conducted to examine pregnancy progression and fetal characteristics following transfer of vitrified bovine nuclear transfer versus in vivo-derived embryos. Nuclear transfer (NT) was conducted using cumulus cells collected from an elite HolsteinFriesian dairy cow. Expanding and hatching blastocysts on Day 7 were vitrified using liquid nitrogen surface vitrification. Day 7 in vivo embryos, produced using standard superovulation procedures applied to Holstein-Friesian heifers (n = 6), were vitrified in the same way. Following warming, embryos were transferred to synchronized recipients (NT: n = 65 recipients; Vivo: n = 20 recipients). Pregnancies were monitored by ultrasound scanning on Days 25, 45 and 75 and a sample of animals were slaughtered at each time point to recover the fetus/placenta for further analyses. Significantly more animals remained pregnant after transfer of in vivo-derived embryos than NT embryos at all time points: Day 25 (95.0 versus 67.7%, P < 0.05), Day 45 (92.8 versus 49.1%, P < 0.01) and Day 75 (70.0 versus 20.8%, P < 0.0). There was no significant difference (P = 0.10) in the weight of the conceptus on Day 25 from NT transfers (1.14 AE 0.23 g, n = 8) versus in vivo transfers (0.75 AE 0.19 g, n = 8). On Day 45, there was no significant difference in the weight of either fetus (P = 0.393) or membranes (P = 0.167) between NT embryos (fetus: 2.76 AE 0.40, n = 12; membranes: 59.0 AE 10.0, n = 11) or in vivo-derived embryos (fetus: 2.60 AE 0.15, n = 6; membranes: 41.8 AE 5.2, n = 4). However, on Day 75 the weight of the fetus and several of the major organs were heavier from NT embryos. These data suggest that morphological abnormalities involving the fetus and the placenta of cloned pregnancies are manifested after Day 45. #
Introduction
The incidence of pregnancy loss in cattle is greater during the embryonic period (conception to the end of organogenesis, Days 1-42) than during the fetal period (completion of organ differentiation to parturition, Days 42-280) or the neonatal period (parturition to Day 28 of extra-uterine life) (reviewed by [1, 2] ). Early embryonic loss, associated with a failure of maternal recognition of pregnancy before Day 18 of gestation accounts for approximately 40% of all pregnancy loss in cattle [1, 3] . The incidence of embryo mortality following transfer of in vivo-derived embryos is similar to that following www.theriojournal.com Theriogenology 68 (2007) [1128] [1129] [1130] [1131] [1132] [1133] [1134] [1135] [1136] [1137] artificial insemination (AI); incidence of abortions decreased to less than 10% after 2 months of gestation in recipients that received in vivo produced embryos from superovulated cows [4] . However, embryos produced in vitro have markedly higher rates of early embryonic, fetal and perinatal loss than that seen after AI or the transfer of in vivo-derived embryos [5, 6] .
The successful production of viable progeny after somatic cell nuclear transfer (SCNT) has been achieved in a wide variety of species, including the first success in sheep [7] and subsequent successes in cattle [8, 9] . Bovine embryos produced by NTare capable of developing to the blastocyst stage with an efficiency of 30-50% which is comparable to that achieved with routine IVF [10] . However, following somatic cell cloning and transfer to surrogate recipients a very limited percentage (0.5-5%) of the reconstructed embryos complete full term development. This is mainly due to a high frequency of postimplantation developmental arrest. Such losses are predominantly during the first trimester of pregnancy but can occur much later [11] .
Early gestational losses of NT embryos are often associated with aberrant placental development [12] [13] [14] . Anomalies in fetal and perinatal stage cloned calves and lambs are heterogeneous, including excessive birth weight, defects in the gastrointestinal, cardiopulmonary, hepatic and renal systems as well as skeletal malformations [15] . The primary cause of such defects in clones is postulated to be epigenetic, based on the observation that abnormalities of clones are not transmitted to subsequent generations [16] .
The high incidence of pregnancy loss and neonatal death following SCNT are hypothesized to result from incomplete nuclear reprogramming; several authors have convincingly demonstrated that the donor somatic cell is reprogrammed such that expression pattern at the blastocyst stage is substantially different from that of the somatic cell prior to nuclear transfer [17, 18] . In the past few years a plethora of papers have been published on mRNA expression in blastocysts derived from nuclear transfer in an effort to explain the very low live birth rates following transfer [11] despite relatively high rates of blastocyst development [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] . Others have looked at gene expression before (Day 16) and after (Day 40) implantation and observed differential expression of genes critical to normal placental development is altered in SCNT bovine embryos [27, 28] .
The objective of this study was to examine pregnancy progression and fetal characteristics following transfer of vitrified bovine blastocysts produced in vitro by somatic cell nuclear transfer or derived in vivo following superovulation, artificial insemination and non-surgical embryo recovery. Fetuses and associated membranes were recovered at approximately Days 25 (beginning of implantation), Day 45 (end of implantation/organogenesis) and Day 75 of pregnancy. Tissue samples derived from this study will be used to analyze differential gene expression in fetuses and fetal membranes derived from AI or SCNT in the future.
Materials and methods

Generation of NT embryos
Nuclear transfer was conducted using cumulus cells. Bovine cumulus oocyte complexes (COCs) were collected from a 4-year-old Holstein dairy cow of high merit, from the University of Connecticut's Kellogg Dairy Center (KDC), by standard oocyte ultrasoundguided retrieval (ovum pickup, OPU). Cumulus cells were expanded to different passages by a brief washing with D-PBS, and subsequently subjected to a 3 min digestion by 0.05% trypsin (ICN, Aurora, OH, 103140) and 0.5 mM EDTA (Baker, Phillipsburg, NJ, 8991) at 37 8C. Cumulus donor cells at passages 5-10 were used for nuclear transfer. Before nuclear transfer, the donor cells were trypsinized, washed by centrifugation, and resuspended in 5% FBS + DMEM. Abattoir oocytes were used for the production of NT embryos. After 20-22 h of in vitro maturation, the oocytes were enucleated. This was confirmed by Hoechst 33342 staining. Using our standard procedure, donor cells with a diameter of 10-15 mm were transferred to the perivitelline space of the recipient cytoplast. Fusion was induced with two pulses of direct current of 1.67 kV/cm for 10 ms each, with an Electorcell Manipulator 200 (BTX, San Diego), and was confirmed by microscopic examination. Oocyte activation was simultaneously induced with the electrical pulses. Further activation of fused embryos was achieved by culture with cycloheximide (CHX, 10 mg/ml; Sigma), cytochalasin D (CD, 2.5 mg/ ml; Sigma), in TCM199 + 7.5% FBS for 1 h and then CHX (10 mg/ml; Sigma) in M199 + 7.5% FBS for an additional 4 h. For the first 48 h, the NT embryos were cultured in CR1aa medium supplemented with 6 mg/ml BSA at 39 8C in a humidified atmosphere of 5% CO 2 , 5% O 2 , and 90% N 2 . Cleaved embryos were further cultured for 5 days in CR1aa medium with 10% FBS and cumulus cell coculture. Blastocyst development was recorded on Day 7 and grade 1 (C1) embryos, classified according to the guidelines of the International Embryo Transfer Society (IETS), were vitrified. Six replicates were carried out with between 114 and 217 reconstructed embryos per replicate. A representative image of Day 7 NT-derived blastocysts used in this study is illustrated in Fig. 1 .
In vivo production of embryos
To produce Day 7 in vivo-derived blastocysts for transfer, Holstein-Friesian heifers were synchronized using a CIDR device (InterAg, Hamilton, New Zealand) for 8 days. Three days before CIDR removal, heifers received 2 ml (15 mg) of prostaglandin F 2a analogue (PG, Prosolvin, Intervet, Dublin, Ireland). Heifers were checked for standing estrus (=Day 0). Beginning on Day 10, animals were superovulated with a total of 12 ml (420 i.u.) of FSH (Folltropin 1 , Bioniche, Inverin, Co. Galway, Ireland) given as twice-daily injections over 4 days on a decreasing dose schedule. An i.m. injection of PGF 2a was administered at the time of the fifth and sixth FSH injection to induce luteolysis. Embryo donors were inseminated with frozen-thawed semen 12 and 24 h after the onset of oestrus. On Day 7 post insemination the number of ovulations was recorded by estimating the number of corpora lutea (CL) by palpation. Donors were then flushed non-surgically with 500 ml of phosphatebuffered saline (PBS) supplemented with 10% FCS. This was filtered through an Emcon 1 filter (Veterinary Concepts, Spring Valley, WI) and searched under a stereomicroscope. The recovered oocytes/embryos were assessed for developmental stage and only grade 1 morula/blastocyst stage embryos, based on IETS guidelines, were selected for transfer. All non-surgical embryo recoveries and embryo transfers were carried out by an experienced commercial operator.
Embryo vitrification
Expanding and hatching blastocysts derived from SCNT ( Fig. 1) as well as those produced in vivo as described above were vitrified on Day 7 using liquid nitrogen surface vitrification [29] . Vitrification solution contained HEPES-buffered TCM199 supplemented with 20% FBS, ethylene glycol and dimethylsulfoxide. A droplet of 1-2 ml vitrification solution containing a single blastocyst was directly dropped onto a cooled surface within 30 s after 3 min incubation in equilibra- tion solution. Embryos were warmed and subsequently washed several times in rehydration solutions and TCM199 + 7.5% FBS.
Embryo transfer
Following warming, embryos were transferred to synchronized recipients. For NT embryos, two embryos were transferred per recipient (n = 65 recipients). In vivo embryos were transferred to a total of 20 recipients; 11 recipients received 2 embryos, and the remaining 9 recipients received 1 embryo.
Pregnancies were monitored by ultrasound scanning on Days 25, 45 and 75 and a sample of animals were slaughtered at each time point to recover the fetal/ placental tissue for further analyses. On Day 25, the entire conceptus was weighed together; on Day 45 the fetus and placenta were weighed separately; on Day 75 the fetus was dissected and the major organs were weighed and the weight of the fetal membranes and number of cotyledons was recorded.
Results
In vitro development of postfusion NT embryos
Based on six replicates, the fusion success following NT was 97% (738/760). A proportion of the fused eggs lysed after 44 h culture; of the viable embryos, 84.1% (549/653) were cleaved 44 h postfusion and 48.7% (318/653) developed to the blastocyst stage at Day 7 and were vitrified (Fig. 1). 
Pregnancy rate
Significantly more animals remained pregnant after transfer of in vivo-derived embryos than NT embryos at all time points: Day 25 (95.0 versus 67.7%, P < 0.05), Day 45 (92.8 versus 49.1%, P < 0.01) and Day 75 (70.0 versus 20.8%, P < 0.01) (Fig. 2) . Despite the fact that 2 SCNT-derived embryos were transferred each time, no twin pregnancies resulted in contrast to the transfer of two in vivo-derived embryos where surviving twin fetuses were noted at Days 25, 45 and 75.
Fetal and organ weights
Although not significantly different (P = 0.10), the weight of the conceptus on Day 25 from the transfer of NT-derived embryos (1.14 AE 0.23 g, n = 8) was heavier than that derived from the transfer of in vivo-derived embryos (0.75 AE 0.19 g, n = 8) (Fig. 3) . A similar pattern was observed on Day 45; although heavier, the difference in the weight of either fetus (P = 0.393) or membranes (P = 0.167) between NT embryos (fetus: 2.76 AE 0.40 g, n = 12; membranes: 59.0 AE 10.0 g, n = 11) or in vivo-derived embryos (fetus: 2.60 AE 0.15 g, n = 6; membranes: 41.8 AE 5.2 g, n = 4) was not significant (Fig. 4) . On Day 75, the weight of the fetus (Fig. 5) , fetal membranes (Fig. 6 ) and major organs (brain, liver, heart, lungs, kidneys and spleen) were compared among the two groups, the latter both with (Fig. 7 , expressed as a percentage of fetal weight) and without (Table 1 ) correction for the weight of the fetus.
Although not significantly different, the mean placental weight at Day 75 was heavier in NT fetuses (242.7 AE 30.1 g) compared to in vivo fetuses (207.1 AE 39.8 g). There was a tendency (P = 0.054) for more cotyledons in the case of NT fetuses (48.3 AE 4.3 versus 58.3 AE 3.8). The mean heart weight at Day 75 was significantly heavier in NT fetuses compared to those derived from in vivo produced embryos (P = 0.028); however, when corrected for fetal weight, the difference was no longer significant (P = 0.1). Similarly, the difference in mean liver weight between the groups approached significance (P = 0.051) with NT fetuses having heavier livers; however, when corrected for the fetal weight this difference disappeared. There was no difference in mean kidney weight, with or without correction. NT fetuses tended to have heavier spleens, both without (P = 0.065) and with (P = 0.85) correction for fetal weight. Similarly, NT fetuses had heavier lungs both without (P = 0.006) and with (P = 0.023) correction. Finally, no significant difference was observed in mean brain weight at Day 75, but when corrected for fetal weight NT fetuses had significantly lighter brains (P = 0.039). 
Discussion
The findings of this study highlight the marked difference in both the incidence and timing of pregnancy loss following embryo transfer between normal in vivo-derived embryos and those derived from SCNT. In addition, differences in fetal and placental characteristics were observed, particularly at Day 75, which may in part explain the differences in late fetal and neonatal survival of animals derived from SCNT.
The pregnancy rate following transfer of in vivoderived embryos was high with little loss between Days 25 and 45 (>90% pregnancy in both cases) and only a minor decrease in pregnancy rate (70%) at Day 75. In contrast, the pregnancy rate following transfer of SCNT-derived embryos was lower at all time points and decreased linearly from Day 25 to 75 (68-21% pregnancy). The pregnancy rate at Day 75 in the SCNT group (21%) is consistent with that reported by Shen et al. [30] (14.4%) who transferred two embryos per recipient following vitrification with the same technique. Loss of pregnancies from the transfer of cloned embryos is increased compared to pregnancies from IVP embryos, resulting in only about 10% of recipients carrying a cloned fetus to term [11, 12, 15, 31] . Heyman et al. [11] monitored the evolution of pregnancy following the transfer of embryos derived from somatic cell cloning, embryonic cloning and IVP in order to detect the occurrence of late gestation losses and their frequency. Based on progesterone concentrations on Day 21, there were no significant differences in the percentages of initiated pregnancies between the groups (55.6-62.7%). Confirmed pregnancy rate by Day 35 using ultrasound scanning was significantly lower in the two somatic cloned groups (27.5-33 .8%) compared with the embryonic clones (49.2%) and IVF embryos (52.9%). This pattern was maintained at Days 50, 70 and 90, in agreement with our results. The incidence of loss between Day 90 of gestation and calving was 43.7% for adult somatic clones and 33.3% for foetal somatic clones compared with 4.3% after embryonic cloning and 0% after IVP [11] .
The lack of a difference in fetal weight between control and SCNT fetuses on Day 45 is consistent with the observations of Lee et al. [15] who did not observe any difference in fetal weight at Day 50 between fetuses derived from AI, IVF or SCNT. In the same study a significant difference in fetal weight at Day 100 was observed between the NT group (320 AE 12 g), IVP (303 AE 12 g) and AI (283 AE 2 g) fetuses. This is in agreement with our observations of a difference in fetal weight at Day 75 (69.9 AE 4.2 g for controls versus 83.2 AE 5.6 for NT).
Many of the observed defects of cloned pregnancies involve the placenta; placentae of cloned calves tend to have fewer but much larger placentomes [31] . We did not observe any difference in the weight of the placental tissue on Day 75 and there were more cotyledons on the cloned pregnancies than those produced from the transfer of in vivo-derived embryos (Table 1) . However, in some cases, individual placentomes were larger on the cloned fetuses (e.g., Fig. 5D ). In the study of Lee et al. [15] , fetal cotyledon formation and vascularization of the chorioallantoic membranes was initiated normally in NT conceptuses, but fewer cotyledons successfully formed placentomes such that by Day 100 the number of placentomes was significantly lower in surviving NT fetuses.
Global gene expression profiling of embryos derived from SCNT, IVF and AI has revealed significant nuclear reprogramming by the blastocyst stage [18] ; the pattern of gene expression of NT embryos was markedly different from that of the donor cells and, surprisingly, more closely resembled that of AI embryos than IVF embryos. Problems may occur during redifferentiation for tissue genesis and organogenesis and it was suggested that small reprogramming errors may be magnified downstream in development. Consistent with this hypothesis, abnormal placental development has been put forward as the main factor limiting success in ruminant pregnancies derived from SCNT. Arnold et al. [27] described altered expression of genes involved in trophoblast development (Mash2, Hand1 and PAG-9) in bovine SCNT conceptuses compared to those derived from AI or IVF prior to (Day 17) and following (Day 40) implantation which could potentially contribute to pregnancy loss.
In conclusion, pregnancy rate after transfer of embryos derived from SCNT resulted in a significant decrease in pregnancy rate between Days 25 and 75 of gestation compared to pregnancies established with normal in vivo embryos. In addition, on Day 75 the weight of the fetus and several of the major organs were heavier from NT embryos. These data suggest that morphological abnormalities involving the fetus and the placenta of cloned pregnancies are manifested after Day 45. However, given that differences in gene expression between control and NT blastocysts exist at Day 7, it would suggest that such perturbations might have an effect further along the developmental axis.
